Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 28, 1998

View Archived Issues

Blocking Presenilin Gene Studied To Battle Alzheimer's

UK Firm Tackles Diabetes With Phosphoglycokines

Tasmanian Families To Serve As Lab For Disease Gene Discovery

Danish Biotechnology Sector In Line For US$50M Boost

Allelix Expands Lilly Alliance; Suspends Hoechst Program

Amrad Reports Positive Phase I Data On Neurological Drug

Irish Stores First To Employ BSE Test To Evaluate Beef

Oxford Asymmetry Seeks £20M In Listing On London Exchange

IDM Gets First CE Mark For Cell Processor

Other News to Note

Elan Reports Positive Data In Phase II Trial For Antegren

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.